Raja Assal

home / authors / raja-assal

Articles

Exploring CAR-T Therapy: Discussing Its Introduction and Shared Decision-Making in Myeloma Treatment

Exploring CAR-T Therapy: Discussing Its Introduction and Shared Decision-Making in Myeloma Treatment

Omar Castaneda Puglianini, MD ;Jammie Freeman, RN ;Raja Assal
December 6th 2024

Panelists discuss how the patient’s journey with multiple myeloma begins with an initial diagnosis followed by first-line treatments and how this informs the decision to consider chimeric antigen receptor T-cell therapy as a subsequent option in their treatment path.

Navigating the Myeloma Journey: Insights from Diagnosis to First-Line Treatment in Standard-Risk Patient

Navigating the Myeloma Journey: Insights from Diagnosis to First-Line Treatment in Standard-Risk Patient

Omar Castaneda Puglianini, MD ;Jammie Freeman, RN ;Raja Assal
December 5th 2024

Panelists discuss how the patient’s journey with multiple myeloma begins with an initial diagnosis followed by first-line treatments and how this informs the decision to consider chimeric antigen receptor T-cell therapy as a subsequent option in their treatment path.

Latest Updated Articles

Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: December 12th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
High CR Rates Noted With Zilovertamab Vedotin/R-CHP in DLBCL
Published: December 9th 2024 | Updated: December 12th 2024
High CR Rates Noted With Zilovertamab Vedotin/R-CHP in DLBCL